AI Enters Drug Discovery Through Major Acquisition

Anthropic has acquired Mithril Medicine to move further into AI powered drug discovery and rare disease research. The deal shows how major technology companies are increasingly looking at healthcare and biotechnology as new markets for AI. HPC can source biotech, medical AI, diagnostics and healthcare technology businesses for pharmaceutical groups and investors.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.